Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Xiaoying L, Mingchao X, Ruiting L, Dalong H, Suping Z, Shuwei Z et al
(2010) reported a 31% reduction in cancer incidence among metformin users compared with users of other antidiabetic drugs (pooled relative risk 0.69, 95% CI 0.61-0.79)
Normally, theres a check-and-balance relationship between trimethylamine and FMO3: when your body produces trimethylamine, FMO3 enzymes break it down
The coadministration of dapagliflozin and metformin HCl immediate-release or extended-release tablets has been studied in adult patients with type 2 diabetes mellitus inadequately controlled on metformin HCl and compared with a sulfonylurea (glipizide) in combination with metformin HCl
Clinical Pearls for Practice Early use lowers long-term CV risk even if baseline A1C is near target